Connect Biopharma Holdings Limited Ordinary Shares (CNTB) is a publicly traded Healthcare sector company. As of May 21, 2026, CNTB trades at $2.45 with a market cap of $134.52M and a P/E ratio of -2.01. CNTB moved +5.71% today. Year to date, CNTB is -3.75%; over the trailing twelve months it is +172.21%. Its 52-week range spans $0.51 to $3.82. Analyst consensus is strong buy with an average price target of $8.38. Rallies surfaces CNTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Connect Biopharma Holdings Limited Ordinary Shares (CNTB) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CNTB moved +5.71% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $2.45 |
| Market Cap | $134.52M |
| P/E Ratio | -2.01 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.82 |
| 52-Week Low | $0.51 |
| Volume | 840 |
| Avg Volume | 0 |
| Revenue (TTM) | $233.00K |
| Net Income | $-64.61M |
| Gross Margin | 0.00% |
4 analysts cover CNTB: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.38.